Jethro Holter
Vorsitzender bei GENETIC ANALYSIS
Vermögen: 188 421 $ am 30.04.2024
Profil
Jethro Holter is currently the Chief Executive Officer at Biotec BetaGlucans AS and the Managing Director at ArcticZymes AS.
Previously, he was the Chief Executive Officer at ArcticZymes Technologies ASA from 2019 to 2023 and held a Director-Research & Development position at Mole Genetics AS.
He earned a doctorate degree from the University of Cardiff.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
31.03.2023 | 80 564 ( 0,16% ) | 188 421 $ | 30.04.2024 |
Aktive Positionen von Jethro Holter
Unternehmen | Position | Beginn |
---|---|---|
GENETIC ANALYSIS | Vorsitzender | 14.05.2024 |
ArcticZymes AS
ArcticZymes AS Medical SpecialtiesHealth Technology Part of ArcticZymes Technologies ASA, ArcticZymes AS is a Norwegian company that manufactures diagnostic substances. The company is based in Tromsø, Norway. Jethro Holter has been the CEO of the company since 2015. | Vorstandsvorsitzender | 01.01.2015 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Jethro Holter
Unternehmen | Position | Ende |
---|---|---|
ARCTICZYMES TECHNOLOGIES ASA | Vorstandsvorsitzender | 18.09.2023 |
Mole Genetics AS
Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | Corporate Officer/Principal | - |
Ausbildung von Jethro Holter
University of Cardiff | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
GENETIC ANALYSIS | Health Technology |
Private Unternehmen | 3 |
---|---|
ArcticZymes AS
ArcticZymes AS Medical SpecialtiesHealth Technology Part of ArcticZymes Technologies ASA, ArcticZymes AS is a Norwegian company that manufactures diagnostic substances. The company is based in Tromsø, Norway. Jethro Holter has been the CEO of the company since 2015. | Health Technology |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | Health Technology |
Mole Genetics AS
Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | Health Technology |